Form EFFECT - Notice of Effectiveness:
SEC Accession No. 9999999995-25-001964
Accepted
2025-06-20 00:15:20
Documents
1
Effectiveness Date
2025-06-18

Document Format Files

Seq Description Document Type Size
1 primary_doc.html EFFECT  
1 primary_doc.xml EFFECT 594
  Complete submission text file 9999999995-25-001964.txt   2073
Mailing Address 10531 4S COMMONS DRIVE SUITE 166-550 SAN DIEGO CA 92127
Business Address 1035 CAMBRIDGE STREET SUITE 18A CAMBRIDGE MA 02141 (617) 798-6700
Ernexa Therapeutics Inc. (Filer) CIK: 0000748592 (see all company filings)

EIN.: 311103425 | State of Incorp.: DE | Fiscal Year End: 1231
Type: EFFECT | Act: 33 | File No.: 333-287954 | Film No.: 251058905
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)